This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Astellas Pharma Gmbh, Medivation Prostate Therapeutics, Inc.. Active years: 2024.
Company Filing History:
1 out of 424 
1 out of 12 Years Active: 2024
Title: The Innovative Journey of Jacqueline Gibbons
Introduction
Jacqueline Gibbons is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of medicine, particularly in the area of combination therapies. Her work has the potential to impact the treatment of various conditions, showcasing her dedication to innovation.
Latest Patents
Jacqueline holds 1 patent for her invention titled "Combination therapy." This patent provides a dosage regimen for the co-administration of enzalutamide and a strong CYP3A4 inducer. This innovative approach aims to enhance the efficacy of treatments, demonstrating her commitment to advancing medical science.
Career Highlights
Throughout her career, Jacqueline has worked with prominent companies in the pharmaceutical industry. She has been associated with Medivation Prostate Therapeutics, Inc. and Astellas Pharma GmbH. Her experience in these organizations has allowed her to develop her skills and contribute to groundbreaking research.
Collaborations
Jacqueline has collaborated with esteemed colleagues, including Joyce Mordenti and Michiel De Vries. These partnerships have fostered an environment of creativity and innovation, leading to the development of her impactful patent.
Conclusion
Jacqueline Gibbons exemplifies the spirit of innovation in the medical field. Her contributions through her patent and collaborations highlight her role as a significant inventor. Her work continues to inspire advancements in combination therapies, paving the way for improved patient outcomes.